| Anjali Kumar, MD | |
|
4160 John R Suite 521, Detroit, MI 48201 | |
| (313) 831-1166 | |
| (313) 831-0020 |
| Full Name | Anjali Kumar |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 52 Years |
| Location | 4160 John R Suite 521, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902988942 | NPI | - | NPPES |
| 2125710 | Medicaid | MI | |
| 1108296251 | Other | MI | BSBSM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | AK039441 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harper University Hospital | Detroit, MI | Hospital |
| Mailing Address | Practice Location Address |
|---|---|
| Anjali Kumar, MD 369 Eckford, Troy, MI 48085 Ph: (248) 689-3012 | Anjali Kumar, MD 4160 John R Suite 521, Detroit, MI 48201 Ph: (313) 831-1166 |
News Archive
Hands up who goes to the doctor when they are feeling well? Hands up who goes to the doctor just to chat about how they can stay well? The fact is most of us drag ourselves off to the doctor only when there are signs of trouble, when we are feeling sick.
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
A new study by researchers at the UCLA Jonsson Comprehensive Cancer Center has identified a novel combination therapy to potentially help overcome resistance to immunotherapy in people diagnosed with advanced lung cancer.
The smoking ban in Wales has not displaced secondhand smoke from public places into the home. A study of 3500 children from 75 primary schools in Wales, published in the open access journal BMC Public Health, found that they were exposed to similar amounts of secondhand smoke before and after legislation, which should reassure those worried that exposure to smoking at home could increase following the ban.
› Verified 2 days ago
Dr. Saba Alan Francis, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 50 E Canfield St, Detroit, MI 48201 Phone: 313-745-4525 | |
Dr. Roopkiranjot Kahlon, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4201 Saint Antoine St, University Health Center 2e, Detroit, MI 48201 Phone: 313-745-4525 | |
Avi Cohen, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Waleed Obaid, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6071 W Outer Dr, Detroit, MI 48235 Phone: 313-966-3250 | |
Lindsey Aurora, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Alexander Garbarino, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Maria Diab, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 800-653-6568 Fax: 313-876-1305 |